Skip to main content
SpringerLink
Log in

Antineoplastics/CAR-T-cell-therapies

Various toxicities: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Bachanova V, et al. Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy. Blood Reviews 40: Mar 2020. Available from: URL: http://doi.org/10.1016/j.blre.2019.100640

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics/CAR-T-cell-therapies. Reactions Weekly 1801, 41 (2020). https://doi.org/10.1007/s40278-020-77701-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-77701-3

Search

Navigation